FOXO1 and Hepatic steatosis: Concerning the effects of n-3 PUFA on Foxo1, eicosapentaenoic acid (EPA) supplementation decreased hepatic steatosis and lowered hepatic FOXO1 protein expression in young Zucker rats [34].